C5 and ischemic stroke: These findings provide evidence for the detrimental role of C5a in brain injury after SAH and are in line with previous studies in which C5aR deficiency as well as treatment with a C5aR antagonist resulted in reduced apoptosis, increased cell viability, and reduced infarct volume after ischemic stroke [47, 48].